Detalhe da pesquisa
1.
Preliminary hazard analysis applied to outsourcing sterile chemotherapy preparations.
J Oncol Pharm Pract
; : 1078155218785239, 2018 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29933726
2.
A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastases.
Exp Hematol Oncol
; 13(1): 41, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38622749
3.
Budget Impact Analysis of Fixed Dose Versus Weight-Based Dosing Regimen of Nivolumab and Pembrolizumab in the Treatment of Non-Small Cell Lung Cancer.
Vaccines (Basel)
; 8(4)2020 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33287161
4.
Pulsed-laser irradiation of multifunctional gold nanoshells to overcome trastuzumab resistance in HER2-overexpressing breast cancer.
J Exp Clin Cancer Res
; 38(1): 306, 2019 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31299997
5.
A successful compartmental approach for the treatment of breast cancer brain metastases.
Cancer Chemother Pharmacol
; 83(3): 573-580, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30610367
6.
Outcome of patients with high risk Myelodysplastic Syndrome (MDS) and advanced Chronic Myelomonocytic Leukemia (CMML) treated with decitabine after azacitidine failure.
Leuk Res
; 39(5): 501-4, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25735917